Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moskowitz

Showing results (321-330 of 347) with videos related to

Pageof 35
Sort By:
American Journal of Respiratory and Critical Care Medicine|September 24, 2020
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More <i>F508del</i> Alleles: Interim Results of an Open-Label Phase 3 Clinical TrialMatthias Griese, Stefano Costa, Rachel W Linnemann, et al.
Pediatric Pulmonology|March 12, 2019
Effects of a primary palliative care intervention on quality of life and mental health in cystic fibrosisDeborah Friedman, Rachel W Linnemann, Lily L Altstein, et al.
Anesthesiology|April 29, 2006
Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosageAshraf A Dahaba, Seth I Perelman, David M Moskowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2006
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsEric E Smith, Danielle G Buckley, Zaining Wu, et al.
Molecular Microbiology|November 29, 2013
A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid AIyarit Thaipisuttikul, Lauren E Hittle, Ramesh Chandra, et al.
The Journal of Urology|June 23, 2009
Preliminary evaluation of a genitourinary skills training curriculum for medical studentsAdam G Kaplan, Surendra B Kolla, Aldrin J R Gamboa, et al.
Nature Communications|September 2, 2014
Magnetic properties of uncultivated magnetotactic bacteria and their contribution to a stratified estuary iron cycleA P Chen, V M Berounsky, M K Chan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2017
The CF-CARES primary palliative care model: A CF-specific structured assessment of symptoms, distress, and copingDeborah Friedman, Rachel W Linnemann, Lily L Altstein, et al.
Pediatric Pulmonology|October 22, 2010
Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infectionSamuel M Moskowitz, Julia C Emerson, Sharon McNamara, et al.
Plos One|September 13, 2011
Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTRRobert L Young, Kenneth C Malcolm, Jennifer E Kret, et al.
Pageof 35

Showing results (321-330 of 347) with videos related to

Sort By:
Pageof 35
American Journal of Respiratory and Critical Care Medicine|September 24, 2020
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More <i>F508del</i> Alleles: Interim Results of an Open-Label Phase 3 Clinical TrialMatthias Griese, Stefano Costa, Rachel W Linnemann, et al.
Pediatric Pulmonology|March 12, 2019
Effects of a primary palliative care intervention on quality of life and mental health in cystic fibrosisDeborah Friedman, Rachel W Linnemann, Lily L Altstein, et al.
Anesthesiology|April 29, 2006
Geographic regional differences in rocuronium bromide dose-response relation and time course of action: an overlooked factor in determining recommended dosageAshraf A Dahaba, Seth I Perelman, David M Moskowitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2006
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsEric E Smith, Danielle G Buckley, Zaining Wu, et al.
Molecular Microbiology|November 29, 2013
A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid AIyarit Thaipisuttikul, Lauren E Hittle, Ramesh Chandra, et al.
The Journal of Urology|June 23, 2009
Preliminary evaluation of a genitourinary skills training curriculum for medical studentsAdam G Kaplan, Surendra B Kolla, Aldrin J R Gamboa, et al.
Nature Communications|September 2, 2014
Magnetic properties of uncultivated magnetotactic bacteria and their contribution to a stratified estuary iron cycleA P Chen, V M Berounsky, M K Chan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2017
The CF-CARES primary palliative care model: A CF-specific structured assessment of symptoms, distress, and copingDeborah Friedman, Rachel W Linnemann, Lily L Altstein, et al.
Pediatric Pulmonology|October 22, 2010
Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infectionSamuel M Moskowitz, Julia C Emerson, Sharon McNamara, et al.
Plos One|September 13, 2011
Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTRRobert L Young, Kenneth C Malcolm, Jennifer E Kret, et al.
Pageof 35